A Long-term Extension Study of PCI-32765 (Ibrutinib)
for Chronic Lymphocytic Leukemia
Drug: Ibrutinib
32 locations incl. Duarte
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT01804686·Phase 3·Recruiting
Connecticut has 1,389 paid clinical trials enrolling now across cities including New Haven, Hartford and Stamford. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .